News for Healthier Living

Researchers' Study Show Advancements in GP38 Contributions to CCHFV and Monoclonal Antibody Therapies

A recent study published in Science Translational Medicine involving scientists from the U.S. Army Medical Research Institute of Infectious Diseases in collaboration with scientists from the Albert Einstein College of Medicine and the University of California-Berkeley have advanced discoveries surrounding the viral glycoprotein GP38 expressed by the Crimean-Congo hemorrhagic fever virus (CCHFV).

April 8, 2025


April 12 2025

April 11 2025

April 10 2025

April 9 2025

April 8 2025

April 7 2025

April 5 2025

April 4 2025

April 3 2025

April 2 2025

April 1 2025

March 31 2025

March 30 2025

March 29 2025